- Home
- ISPC vs BDRX Comparison
ISPC vs BDRX Comparison
Compare ISPC & BDRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ISPC | BDRX |
|---|---|---|
| Founded | 2009 | 2000 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Precision Instruments | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.7M | 2.4M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | ISPC | BDRX |
|---|---|---|
| Price | $0.44 | $5.02 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | 450.6K | ★ 1.7M |
| Earning Date | 11-17-2025 | 09-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $3,352,744.00 | N/A |
| Revenue This Year | $35.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.39 | $3.58 |
| 52 Week High | $4.66 | $92.00 |
Technical Indicators
Market Signals| Indicator | ISPC | BDRX |
|---|---|---|
| Relative Strength Index (RSI) | 36.94 | 47.09 |
| Support Level | $0.39 | $4.00 |
| Resistance Level | $0.53 | $8.94 |
| Average True Range (ATR) | 0.07 | 1.25 |
| MACD | 0.02 | 0.18 |
| Stochastic Oscillator | 20.22 | 21.54 |
Price Performance
Historical ComparisonAbout ISPC iSpecimen Inc.
iSpecimen Inc is a technology-driven company focused on connecting life science researchers who need human biofluids, solid tissues, and hematopoietic stem and immune cells for their research, with the available biospecimens. The company generates revenue by procuring various specimens from hospitals, laboratories, and other supply sites. Geographically, it has a presence in the Americas; Europe, the Middle East, Africa, and Asia Pacific, which majority, comes from the Americas.
About BDRX Biodexa Pharmaceuticals plc
Biodexa Pharmaceuticals PLC is a clinical-stage biopharmaceutical company focused on developing a pipeline of products to treat diseases that have unmet medical needs. These include familial adenomatous polyposis (FAP), non-muscle invasive bladder cancer (NMIBC), type 1 diabetes (T1D), and rare or orphan brain cancers.